Search
for

    Sort by

    Research 511–540 of 1000+

    1. Prevalence of hair loss in Egyptian people after covid -19 vaccination. 2023
    2. IL-17 Expression in the Perifollicular Fibrosis in Biopsies From Lichen Planopilaris The American Journal of Dermatopathology · 2022
    3. 31810 The National Paediatric Alopecia Areata Registry in Russia: An overview Journal of the American Academy of Dermatology · 2022
    4. Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment 2015
    5. Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia International Journal of Dermatology · 2023
    6. Effects of oral minoxidil on nails: a cross‐sectional analysis International Journal of Dermatology · 2023
    7. Shared decision-making in central centrifugal cicatricial alopecia Clinical and Experimental Dermatology · 2024
    8. The microbiome in patients with atopic dermatitis Journal of Allergy and Clinical Immunology · 2018 · 365 citations
    9. JAK inhibitors in dermatology: The promise of a new drug class Journal of the American Academy of Dermatology · 2017 · 355 citations
    10. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019 · 277 citations
    11. Integrin signalling regulates YAP/TAZ to control skin homeostasis Development · 2016 · 266 citations
    12. Weakly supervised learning of biomedical information extraction from curated data BMC Bioinformatics · 2016 · 232 citations
    13. BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer Thyroid · 2014 · 188 citations
    14. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity European Journal of Endocrinology · 2020 · 175 citations
    15. Budesonide for maintenance of remission in Crohn's disease Cochrane library · 2014 · 156 citations
    16. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Journal of the American Academy of Dermatology · 2021 · 138 citations
    17. The Role of Vitamins and Minerals in Hair Loss: A Review Dermatology and Therapy · 2018 · 134 citations
    18. The use of cyclosporine in dermatology: Part I Journal of the American Academy of Dermatology · 2010 · 131 citations
    19. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma ˜The œoncologist · 2016 · 127 citations
    20. Targeting the Janus Kinase Family in Autoimmune Skin Diseases Frontiers in Immunology · 2019 · 124 citations
    21. New Antifungal Agents and New Formulations Against Dermatophytes Mycopathologia · 2016 · 113 citations
    22. A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth Cell Stem Cell · 2019 · 101 citations
    23. Topical Ruxolitinib for the Treatment of Alopecia Universalis JAMA dermatology · 2015 · 96 citations
    24. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents Drugs · 2019 · 90 citations
    25. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆ Annals of Oncology · 2020 · 86 citations
    26. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials British Journal of Dermatology · 2020 · 86 citations
    27. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata Journal of the American Academy of Dermatology · 2017 · 83 citations
    28. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population JAMA Dermatology · 2023 · 75 citations
    29. Dupilumab in Inflammatory Skin Diseases: A Systematic Review Biomolecules · 2023 · 72 citations
    30. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology The BMJ · 2013 · 70 citations